Transfusion and Apheresis Science
Volume 28, Issue 1 , Pages 25-34 , February 2003

Extracorporeal photochemotherapy: a historical perspective

  • Farhad Heshmati

      Affiliations

    • Unité de Médecine Transfusionnelle Service de Médecine Interne Hôpital Cochin, 33 rue du Fg St Jacques 75014 Paris, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-15-8412672; fax: +33-15-8412675
    • ,
  • Georges Andreu

      Affiliations

    • EFS Centre Atlantique, Tours, France

References 

  1. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N. Engl. J. Med. 1987;316:297–303
  2. Menkes CJ, Andreu J, Heshmati F, Hilliquin P. Treatment of refractory rheumatoid arthritis by extracorporeal hotochemotherapy. Brit. J. Rheumatol. 1992;31:789–790
  3. Rook AH, Freundich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, et al.  Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch. Dermatol. 1992;128:337–346
  4. Knobler RM. Extracorporeal photochemotherapy for the treatment of lupus erythematosus: preliminary observations. Springer Semin. Immunopathol. 1994;16:323–325
  5. Rook AH, Jesagothy BV, Heald P, et al.  Extracorporeal photochemotherapy for drug resistant pemphigus vulgaris. Ann. Int. Med. 1990;112:303–305
  6. Costanzo Nordin MR, Hubbel EA, O’ Sullivan RJ, Johnson MR, Mullen GM, Heroux AL, et al  Photopheresis versus corticosteroı̈ds in the therapy of heart transplant rejection. Circulation. 1992;86:242–250
  7. Dall’Amico R, Messina C. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Ther. Apher. 2002;6(4):296–304
  8. Andreu G, Leon A, Heshmati F, Tod M, Baudelot J, Menkes CJ, et al.  Extracorporeal photochemotherapy (ECP): evaluation of two techniques and use in connective tissues disorders. Transfus. Sci. 1994;15(4):443–454
  9. Andreu G, Heshmati F, Boccaccio C, Tod M, Menkes CJ. Treatment of refractory rheumatoid arthritis (RA) by UVA/8 MOP extracorporeal photochemotherapie (ECP). AABB 44th Annual Meeting, Baltimore, November 9–14, 1991
  10. Edelson RL. Transimmunization: science catches up to the clinical success. Transfus. Apher. Sci. 2002;26:177–180
  11. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vewels BR. Apoptosis induction of ultraviolet A and photochemotherapy in cutaneous T cell lymphoma; relevance to mechanism of therapeutic action. J. Invest. Dermatol. 1996;107:235–242
  12. Cohen IR. Regulation of auto immune disease: physiological and therapeutic. Immunol. Rev. 1986;94:5–21
  13. Berger CL, Hanlon D, Kanada D, Girardi M, Edelson RL. Transimmunization, a novel approach for tumor immunotherapy. Transfus. Apher. Sci. 2002;26:205–216
  14. Moor AC, Schmitt IM, Beijersbergen van Henegouwen GM, Chimenti S, Edelson RL, Gasparro FP. Treatment with 8-MOP and UVA enhances MHC class I synthesis in RMA cells: preliminary results. J. Photochem. Photobiol. 1995;29:193–198
  15. Hanlon DJ, Berger CL, Edelson RL. Photoactivated 8-methoxypsoralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes. Int. J. Cancer. 1998;78(1):70–75
  16. Amigorena S. Présentation antigenique par les cellules dendritiques. Médecine/Science. 1999;15:931–938
  17. Fahmy IR, Abushady H. Ammi majus Linn: pharmacological study and isolation of a christalline constituent, Ammoidin. Q. J. Pharm. Pharmacol. 1947;20:281–291
  18. Parrish JA, Fitzpatrick TB, Tannenbaum L, Pathak Ma. Photo chemotherapy of psoriasis with oral methoxalen and long wavelength ultraviolet light. N. Engl. J. Med. 1974;29:1207–1211
  19. Gilchrest BA. Methoxalen photochimiotherapy for mycosis fungoides. Cancer Treat. Rep. 1979;63:663–667
  20. Heald P, Rook A, Perez MI, Wintroub B, Knobler R, Jegasothy B, et al.  Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J. Am. Acad. Dermatol. 1993;28(6):1023–1024
  21. Di Renzo M, Rubegni P, De Aloe G, Paulesu L, Pasqui AL, Andreassi L, et al.  Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. Immunology. 1997;92(1):99–103
  22. Karolak L, Tod M, Leon A, Heudes AM, Petitjean O, Laroche L. In vitro kinetics of 8-methoypsoralen penetration into human lymphoid cells. Photodermatol. Photoimmunol. Photomed. 1992;9(2):58–60
  23. Mark LB, Bruno MM, Howard JE, Randall FR, Ugolino L, Roberto DA, et al.  Photopheresis for the prevention of rejection in cardiac transplantation. NEJM. 1998;339(24):1744–1751 (à corriger)
  24. Andreu G, Achkar A, Couetil JP, Guillemain R, Heshmati F, Amrein C, et al.  Extracorporeal photochemotherapy treatment for acute lung rejection episode. J. Art. Lung Transpl. 1995;14:793–796
  25. Heshmati F, Tavakoli R, Michel A, Achkar A, Guillemain R, Couetil JP, et al.  Extracorporeal photochemotherapy: a treatment for organ graft rejection. Ther. Apher. 1997;1(2):121–125
  26. Heshmati F, Achkar A, Couetil JP, Rochemaure J, Andreu G. Extracorporeal photochemotherapy (ECP) for the treatment of acute lung rejection (ALR) and bronchiolitis obliterans syndrome (BOS) after heart–lung (HLTX) or lung transplantation (LTX). Congrès de l’American Association of Blood Banks, Denver, October 1997
  27. Horina JH, Mülleger RR, Horn S, Holzer H, Halwachs G, Kerl H, et al.  Photopheresis for renal allograft rejection. Lancet. 1995;346:61
  28. Rossetti F, Dall’amico R, Crovetti G, Messina C, Montini G, Dini G, et al.  Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transpl. 1996;18(Suppl 2):175–181
  29. De-Misa RF, Azana JM, Harto A, Ledo A. Extracorporeal photochemotherapy in the treatment of severe psoriatic arthropathy. Br. J. Dermatol. 1992;127:448
  30. Prinz B, Nachbar F, Plewig G. Treatment of severe atopic dermatitis with extracorporeal photopheresis. Arch. Dermatol. Res. 1994;287:48–52
  31. Reinisch W, Nahavandi H, Santella R, Zhang Y, Gasché C, Moser G, et al.  Extracorporeal photochemotherapy in patients with steroid-dependent Crohn disease: a prospective pilot study. Aliment. Pharmacol. Therap. 2001;15(9):1313
  32. Bécherel PA, Bussel A, Chosidow O, Rabian C, Piette IC, Francès C. Extracorporeal photochemotherapy for chronic erosive lichen planus. Lancet. 1998;351(9105):805
  33. Ben Nun A, Wekerle H, Cohen IR. Vaccination against autoimmune encephalomyeletis with T lymphocyte line cells reactive against myeline basic protein. Nature. 1981;292:60–61
  34. Berger CL, Perez MI, Laroche L, Edelson R. Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoactivated lymphocytes. J. Invest. Dermatol. 1990;94(1):52–57
  35. Cohen IR, Holoschitz J, van Eden W, Frenkel A. T lymphocyte clones illuminate pathogenesis and effect therapy of experimental arthritis. Arth. Rheum. 1985;28:841–845
  36. Perez MI, Edelson RL, John L, Laroche L, Berger CL. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Yale J. Biol. Med. 1989;62:595–609
  37. Pepino P, Berger CL, Fuzesia , Panza A, Piesena RN, Gutierrez C, et al.  Primate cardiac allo-and-xenotransplantation: modulation of the immune response with photochemotherapy. Eur. Sur. Res. 1989;21:105–113
  38. Heshmati F, Andreu G, Michel A, Takavoli R, Houssin D. Efficiency of the association of extracorporeal photochemotherapy and cyclosporine in the prevention of heterotopic heart allograft rejection in rat. WAA 5th International Congress, Houston 1994, March 9–12
  39. Berger CL, Hanlon D, Kanada D, Girardi M, Edelson RL. Transimmunization, a novel approach for tumor immunotherapy. Transfus. Apher. Sci. 2002;26(3):205–216
  40. Gasparro FP, Felli A, Schmitt M. Psoralen photobiology––the relationship between DNA damage, chromatin structure, transcription and immunogenetic effects. Recent Results Cancer Res. 1997;143:101–127
  41. Tambur AR, Ortegel JW, Morales A, Gebel HM, Tharp MD. Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis. Transpl. Proc. 2000;32:747–748
  42. Nestle FO, Banchereau J, Hart D. Dendritic cells: on the move from bench to bedside. Nat Med 2001;7(7)
  43. Zitvogel L, Faure F. L’immunité antitumorale: des concepts à l’immunothérapie active spécifique. Médecine/Science. 1999;15:939–949
  44. Luft T, Jefford M, Luetjens P, Toy T, Hochrein H, Masterman KA, et al.  Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets. Blood. 2002;100(40):1362–1372
  45. Liu YJ, Kanzler H, Soumalis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2001;2:558–589
  46. Rook AH, Gottlieb SL, Wolfe JT, Vowels BR, Sood SS, Niu Z, et al.  Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis. Clin. Exp. Immunol. 1997;107(Suppl 1):16–20
  47. French LE, Rook AH. T cell clonality and the effect of photopheresis in systemic sclerosis and graft versus host disease. Transfus. Apher. Sci. 2002;26(3):191–196
  48. Girardi M, Schechner J, Glusac E, Berger C, Edelson R. Transimmunization and the evolution of extracorporeal photochemotherapy. Transfus. Apher. Sci. 2002;26(3):181–190
  49. Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transpl. 2001;28(2):121–129
  50. Tanaka J, Imamura M, Kasai M, Hashino S, Kobayashi S, Noto S, et al.  The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease. Bone Marrow Transpl. 1997;19(6):571–576
  51. Gorgun G, Alcindor T, Rao R, Foss F. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood. 2002;100(3):941–947
  52. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, et al.  Reciprocal control of T helper cell and dendritic cell differentiation. Sci. Mag. 1999;283(5405):1183–1186
  53. Dippel IE, Schrag H, Goerdt , Ofanos CE. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma. Lancet. 1997;350(9070):32–33
  54. Costanzo-Nordin MR, Hubbell EA, O’Sullivan EJ, Johnson MR, Mullen GH, Heronx AL, et al.  Successful treatment of heart transplant rejection with photopheresis. Transplantation. 1992;53:808–815

PII: S1473-0502(02)00097-6

doi: 10.1016/S1473-0502(02)00097-6

Transfusion and Apheresis Science
Volume 28, Issue 1 , Pages 25-34 , February 2003

Article Tools

* Image Usage & Resolution